Ubiquitination of Human Leukocyte Antigen (HLA)-DM by Different Membrane-associated RING-CH (MARCH) Protein Family E3 Ligases Targets Different Endocytic Pathways-Reference-Cited by-同舟云学术

Ubiquitination of Human Leukocyte Antigen (HLA)-DM by Different Membrane-associated RING-CH (MARCH) Protein Family E3 Ligases Targets Different Endocytic Pathways

Published:2012-03 Issue:10 Volume:287 Page:7256-7264
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Jahnke Martin,Trowsdale John,Kelly Adrian P.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference50 articles.

1. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens;Kvist;Cell,1982

2. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain;Roche;Nature,1991

3. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail;Pieters;J. Cell Sci.,1993

4. An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization;Bremnes;J. Cell Sci.,1994

5. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules;Morris;Nature,1994

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer;Journal of Virology;2024-01-16

2. Ubiquitination of Major Histocompatibility Complex II Changes Its Immunological Recognition Structure;International Journal of Molecular Sciences;2023-12-03

3. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer;2023-11-04

4. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis;Cell Death & Differentiation;2023-06-19

5. The role of MARCH9 in colorectal cancer progression;Frontiers in Oncology;2022-09-16